SBFM — Sunshine Biopharma News Story

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapValue Trap

Brief: Sunshine Biopharma Says Health Canada Approves Atenolol For Treating Cardiovascular Conditions

31/08/2026 15:28

BRIEF-Sunshine Biopharma Says Health Canada Approves Atenolol For Treating Cardiovascular Conditions

Aug 31 (Reuters) - Sunshine Biopharma Inc SBFM.O:

SUNSHINE BIOPHARMA: HEALTH CANADA APPROVES SUNSHINE BIOPHARMA'S ATENOLOL FOR TREATING AND MANAGING CARDIOVASCULAR CONDITIONS

Further company coverage: SBFM.O